CXCL9, CXCL10, and CXCL11 are upregulated in macrophages following immune checkpoint inhibitor treatment and associated with increased CD8+ T-cell infiltration into tumors [62], and they are found to be downregulated in COPD macrophages [54]. The gene discussed is CXCL9; the disease is chronic obstructive pulmonary disease.